Abiopharma

New Form 8-K - 4D Molecular Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0000950170-25-106243 Size: 324 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits